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Table 1 Pollen types found in the study area and their monthly concentration (grains/m3 per mo) during 
2004 
Taxa Month 
Jan. Feb. Mar. Apr. May June July Aug. Sept. Oct. Nov. Dec. Jan. Total 
Acacia farnesiana o 2 43 20 2 o 5 o o o 3 o o 76 
Acalypha spp 9 2 21 65 28 4 2 32 30 1 o o o 192 
Agave spp o 2 15 o o o o o o o o o o 17 
Alnus glutinosa 8 17 15 8 o o o o 12 o o o 24 83 
Alternatera spp o o o o 8 o o o o o o o o 8 
J\rnaranthaceae/ 3 17 28 47 212 95 48 122 72 108 33 447 25 1256 
Chenopodiaceae 
Ambrosía spp 5 15 52 17 108 9 49 97 75 127 30 248 77 909 
Apiaceae spp o o o 1 6 o o o o o o o o 6 
Argemone mexicana o 1 5 26 1 o o o o o o o o 32 
\..... Artemisia spp o o 1 o 9 o o 19 o 38 3 o o 71 
Aster spp o o 6 4 1 o o o 4 o o 1 o 16 
Bauhinia spp o o 3 3 10 o o o o o o o o 16 
Bouganvillae spp o o o 9 o o o o o o o o o 9 
Caesalpinia mexicana o o 5 o o o o o o o o o o 5 
Callistemon speciosus o o o o 66 7 o o o 1 o o o 75 
Carya spp o 1 46 66 47 9 1 o o 29 2 o o 201 
Casuarina equisetifolia o o 1 o o 2 o o o 20 9 1 11 43 
Celtis spp 3 39 215 70 109 420 49 203 185 127 19 107 o 1548 
Citrus spp o o o o 1 o o o o o o o o 1 
Compositae o o o 1 24 o 1 2 o o o o o 27 
Cupressus spp 266 273 82 43 2 6 o o 32 101 42 40 331 1218 
Cyperus rotundifolia o 1 22 21 14 5 2 o o 2 o o o 66 
Ehretia anacua o o 51 8 5 2 o o o o o o o 65 
Ephedra spp 1 1 o o 3 o o o o o o o o 4 
Erythrina spp o o o o 1 o o o o o o 294 o 295 
Eucalyptus spp 1 1 4 o o o 2 o o 37 2 o o 46 
Fouquieria splendens o o 7 1 8 17 o o o o o o o 33 
Fraxinus spp 430 5837 512 237 10 o 2 o 11 37 1 1 35 7112 
Grainineae/Paoceae 22 29 52 67 120 158 86 116 251 191 64 826 71 2051 
Helianthus annus 1 1 4 20 44 4 5 1 2 59 28 4 o 172 
Hippeastrum equestre o o o o o o 1 o o o o o o 1 
Jacaranda mimosifolia o o 371 137 31 9 2 1 o o o o o 550 
Junglans spp o 2 22 81 29 1 o o o o o o o 135 
Langerstroemia indica o o o o o 3 7 o o o o o o 10 
Lantana cámara o o o o o o o o o o o o o o 
Leucaena leucocephala o o 42 15 1 9 14 115 o 4 o o o 200 
Leucophyllum frutescens o o 2 16 o o o o o o o o o 18 
Ligustrum lucidum 2 9 187 150 33 66 18 5 o 18 1 o 1 491 
Magnofolia grandiflora o o o o 31 o o o o o o o o 31 
Malvaceace o o o o 7 8 o 15 o o o o o 29 
Mimosa malacophylla o o 178 68 44 37 37 63 6 o 11 o o 445 
Morus spp 5 1417 418 155 76 23 23 o 1 o o o o 2118 
Palma e 1 5 8 o 3 o o o o o o o 1 17 
Parietaria spp 25 131 645 126 120 59 97 63 100 53 12 1 6 1439 
Parkinsonia aculeata o o 8 3 3 16 2 5 o o o o o 37 
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Table 1 Continued 
Taxa Month 
Jan. Feb. Mar. Apr. May June July Aug. Sept. Oct. Nov. Dec. Jan. Total 
Parthenium 5 16 80 161 103 187 37 32 o o o o 2 624 
hysteophorus 
Persea americana 
Phitecellobium 
Pinus spp 
Platanus occidentalis 
Populus spp • 
Prosopis spp 
runus pérsica 
teris longifolia 
uercus spp 
ododendron 
icinus communis 
Rosaceae 
alix spp 
apium sebiferum 
chrankia uncinata 
elaginella spp 
olanum spp 
amarix gálica 
radescantia 
virginiana 
inca rosea 
ashingtonia filifera 
ucca spp 
ea mays 
o o 2 o o 
o o o o o 
2 45 592 182 117 
o 211 87 11 o 
o 3 18 3 o 
o 3 138 89 96 
o 4 o o o 
o o o o o 
1 222 108 69 38 
o 2 2 5 o 
14 
o 
o 
o 
o 
o 
o 
o 
o 
39 148 119 103 
o 
o 
o 
o 
o o 1 o 
16 145 226 20 
o o o o 
o o o o 
o 2 o o 
o 1 31 o 
o o 2 o 
o o o 1 
o 
o 
o 
o 
8 
2 
o 
o 
2 
37 
o 
o 
o 
44 
11 
o 
rain collection was done according to the recom-
endations of the Pan-American Aerobiology Asso-
iation using a Hirst 7-day recording air sampler 
Burkard Manufacturing Co., Hertfordshire, U.K.), 
ith an airflow volume of 10 L/minute, installed on 
e roof of a four-story building of the "Dr. Jose 
leuterio Gonzalez" University Hospital, 12 m off 
e ground, and located in the western part of the 
ity of Monterrey, Nuevo Leon (altitude, 540 m 
hove sea level; coordinates, north 27°49' and south 
3°11' north latitude; east 98°26' and west 101 º14' 
est longitude). 
The particles were trapped on Melinex (Du Pont, 
SA) transparent polyester film (345 mm with a 
ilicon solution asan adhesive) mounted on a clock-
ork-driven drum, which contains a sampling plate 
at moves at 2 mm/hour; this allows hourly calcu-
tions of air particles. The collection drum rotates 
ompletely during 1 week of sampling. The tape was 
emoved weekly and cut into seven pieces with each 
piece representing a day of sampling (48 mm of 
aampling). Afterward, the strips of tape were 
Allergy and Asthma Proceedings 
o 
1 
57 
o 
o 
22 
o 
2 
10 
o 
o 
1 
43 
o 
o 
2 
o 
o 
1 
1 
36 23 
o o 
36 29 
o o 
o 1 
o o 
o o 
21 24 
o o 
o o 
51 14 
o 1 
o 1 
1 
o 
31 
o 
o 
25 
o 
o 
o 
1 
46 
o 
15 
o 
o 
o 
2 
88 
o 
o 
o 
o 
o 
o 
o 
o 
o 
o 
o 
o 
o 
o 
o 
49 
o 
3 
11 
o 
o 
4 
28 
1 
o 
o 
o 
o 
o 
o 
10 
o 
o 
o 
o 
o 
1 
o 
87 
o 
3 
28 
o 
o 
o 
52 
12 
o 
o 
o 
o 
o 
o 
18 
o 
o 
o 
o 
o 
o 
o 
so 
o 
o 
o 
o 
o 
o 
2 
o 
o 
o 
o 
o 
o 
o 
1 
o 
o 
o 
o 
o 
o 
o 
4 
o 
8 
o 
o 
o 
o 
o 
o 
o 
2 
o 
o 
o 3 
o 2 
3 1103 
o 308 
o 24 
o 374 
o 4 
o 2 
o 449 
o 11 
67 
o 
o 
o 
o 
o 
o 
o 
o 
o 
o 
o 
o 
785 
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500 
39 
1 
2 
37 
215 
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mounted in layers of glycerin and safranine on a 
slide. The works by Kremp,19 Erdman,2º·21 Faegri e 
Iversen,22 and Kapp23 were used to identify pollen. 
Trained personnel from the School of Biologic Sci-
ences of the Universidad Autónoma de Nuevo Leon 
counted and identified with a light microscope 
(40X), with four longitudinal sweeps. A correction 
factor was applied by multiplying the number of 
grains observed by 0.54 to obtain the real number of 
grains per cubic meter of air. 
A daily count of the pollen identified was made daily 
for the 365 days that the study !asted. The average 
daily count of pollen was obtained by adding the daily 
pollen count of each month and dividing it by the total 
number of days corresponding to that month. In this 
way, the average count of pollen particles per cubic 
meter per day of sampled air was reported. We also 
determined the total monthly count of each pollen 
identified and the pollination period (PP). The begin-
ning of the PP was established when 5% of the total 
count was reached and lasted until it reached 95% of 
the total.24 
343 
Table 1 Pallen types found in the study area and their monthly concentration (grains/m3 per mo) during 
2004 
Taxa Month 
Jan. Feb. Mar. Apr. May June July Aug. Sept. Oct. Nov. Dec. Jan. Total 
Acacia farnesiana o 2 43 20 2 o 5 o o o 3 o o 76 
Acalypha spp 9 2 21 65 28 4 2 32 30 1 o o o 192 
Agave spp o 2 15 o o o o o o o o o o 17 
Alnus glutinosa 8 17 15 8 o o o o 12 o o o 24 83 
Alternatera spp o o o o 8 o o o o o o o o 8 
Amaranthaceae/ 3 17 28 47 212 95 48 122 72 108 33 447 25 1256 
Chenopodiaceae 
Ambrosía spp 5 15 52 17 108 9 49 97 75 127 30 248 77 909 
Apiaceae spp o o o 1 6 o o o o o o o o 6 
Argemone mexicana o 1 5 26 1 o o o o o o o o 32 
\..._ Artemisia spp o o 1 o 9 o o 19 o 38 3 o o 71 
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Bauhinia spp o o 3 3 10 o o o o o o o o 16 
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Casuarina equisetifolia o o 1 o o 2 o o o 20 9 1 11 43 
Celtis spp 3 39 215 70 109 420 49 203 185 127 19 107 o 1548 
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Table 2 Average pollen count for trees, weeds, and grasses per month, reported in grains/m3 per day from 
January 2004 to January 2005 
Month 
January 2004 
February 2004 
March 2004 
April 2004 
May 2004 
June 2004 
July 2004 
August 2004 
September 2004 
October 2004 
November 2004 
December 2004 
January 2005 
Year average (grains/m3 per day)• 
Percentage corresponding to the total pollen count 
•Average number of grains per cubic meter per day. 
2SO 
l!GO 
t ,, 
-'E 1SO 
l 
I! 
l:J 
100 
!IO 
o 
RESULTS 
During the period of study we identified 70 different 
types of ~ollen. The total pollen studied was 25,918 
grains/m . In Table 1 the pollen types found are de-
scribed, as well as the total monthly concentration of 
pollen per truca. 
The months with the highest pollen concentration 
were February, with an average of 289 grains/ m3 per 
day, and March with 142 grains/m3 per day. The 
months of July and November had the lowest concen-
tration with a total of 20 and 11 grains/ m3 per day, 
respectively (Table 2). 
Most of the pollen corresponded to trees (72% of the 
total), followed by weeds (20.3%), and last, by grass 
pollen (7.7%). Tree pollen count was higher in the first 
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Trees Weeds 
49.5 2.5 
281 6.5 
106.2 34.1 
59.8 18.9 
28.2 23.3 
26.1 14.7 
7.4 9.7 
15.4 16.2 
11.1 9.7 
16.2 14.6 
4.8 3.9 
14.7 22.S 
29.4 6.9 
54 15 
72% 20.3% 
--ltees 
---Weecls 
..... Gral& 
Grasses Total % 
1.4 53.4 5.82 
1.0 288.5 31.39 
1.6 141.9 15.45 
2.2 80.9 8.81 
3.8 55.3 6.15 
5.2 46 5.02 
2.7 19.8 2.19 
3.7 35.3 3.85 
8.3 29.1 3.16 
6.2 37 4.02 
2.1 10.8 1.18 
26.6 63.8 6.95 
4.4 40.7 4.73 
6 75 
7.7% 100 
Figure 1. Pallen count average of trees, 
weeds, ami grasses during study. 
half of the year; the months with the highest concen-
tration were February and March. Weed pollen was 
higher in March, May, and December. The highest 
concentration of grass pollen was reported in Decem-
ber (Table 2 and Fig. 1). 
Of ali the collected pollen in the year, Fraxinus spp. 
was the most important in quantity with a total of 7112 
grains/m3. A peak occurred in February with a daily 
average of 201 grains/m3. This pollen corresponded to 
27.5% of the total count of pollen in the year. 
The most frequently identified tree pollen was Fraxinus 
spp, with high concentrations in January and April; 
Moms spp, present from February to May, reaching its 
highest concentration in February; Celtis spp, present 
most of the year (March to December), presented its 
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highest concentration in June; Cupressus spp, a1so present 
most of the time, mainly from October to April, had its 
highest concentration in January; and Pinus spp, which 
was present from February to August, had the highest 
concentration in March. Table 1 corresponds to the aver-
age pollen count of grains per cubic meter per month of 
the main trees identi.fied during the study. 
The predom.inant weed pollen was Parietaria spp, 
present at ali times during the year with an average of 
4 grains/m3 per day. It predom.inated from February to 
May. The highest concentration was reported at 21 
grains/m3 per day in March. The pollen of Amaran-
thaceae/Chenopodiaceae was present ali year; mostly 
in the months of May, June, August, October, and 
December, its highest concentration was reported in 
December. The pollen of Ambrosía spp. was also 
present ali year, mainly from August to October, De-
cember, and January, December being the month with 
the highest concentration reported at 8 grains/m3 per 
day. Other weeds identified in smalier quantities were 
Helianthus annus, Parthenium hysteophorus, and Tamarix 
galica {Table 1). The PP for grasses was from the middle 
of April to January; the months with the highest daily 
average corresponded to December, with 27 grains/m3 
per day; September, with 8 grains/m3 per day; and 
October, with 6 grains/m3 per day with a predomi-
ance of the Gram.ineae/Poaceae families {Table 2). 
Aeroallergens are complex molecules that contain an-
·genic proteins, which actívate and degranulate mast 
lls by specific IgE mechanisms with the subsequent 
ease of inflammatory mediators that generate a char-
cteristic allergic response.25.26 Most pollen with aller-
enic potential is transported by the wind and is named 
emophilous.15,27 The species that disperse pollen into 
e atmosphere usually correlate with the flora of each 
·on but this is nota rule.5,6,28 Although an increase in 
ollen levels can cause an increase in allergic sensitiza-
·on, the level of pollination does not always coincide 
·th the sensitiz.ation pattem of certain plants in the same 
ason.4•7 This is an important consideration when pre-
'bing allergen-specific immunotherapy.29--11 
Not ali pollen has the capacity to produce an aliergic 
action. This capacity depends on factors such as pro-
in components that constitute th:i;ollen grain, plant 
· tribution, pollen flotation, etc.32 
Sorne authors believe that the maximum concentra-
'on of pollen and its duration is more important than 
e correlation of symptoms-pollen counts for pa-
'ents with pollinosis.36 Because of the characteristics of 
ollen types, it is not always possible to linearly cor-
elate allergy symptoms (rhinorrhea, sncezing, itching, 
etc.) and atmospheric pollen counts. The Burge catego-
rization system is an attempt at a clinical approxirna-
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tion for this relationship.34 Extremely sensitive patient 
will experience symptoms with levels of pollen be 
tween 1 and 15 grains/m3 for trees, 1 and 5 grains/m 
in grasses, and 1and10 grains/m3 in weeds. However 
most individuals will present sym¡ toms with variablE 
pollen counts (16-90 grains/m from trees, 6-2( 
grains/m3 from grasses, and 11-50 grains/m3 from 
weeds).34 For example, Negriti et al. reported symp-
toms in aliergic patients to Parietaria spp with 10-15 
grains/m3 per day at ~80 grains/m3 per da:/' almost 
90% of the patients presented symptoms.3 Among 
weeds, Parietaria spp. was common with counts of at 
least 10 grains/m3 per day for 30 days during the year, 
but reached counts of 99 grains/m3 per day (March 16, 
2004) with a wide PP. Other weeds that had important 
levels and considerable amounts were Amaranthaceae/ 
Chenopodiaceae (22 days) as well as Ambrosía spp. (20 
days). Parietaria spp. is special in this group because 
although it is frequent, it is not included in the aeroal-
lergen panel that we use in our center. 
Table 3 shows the taxa that had pollen counts equal 
or higher than those that cause symptoms according to 
the Burge categorization system, number of days with 
high levels, and the PP. Tree pollen corresponded to 
72% of the total count during the year, Fraxinus spp. 
reported the highest counts, its importance seems lim-
ited to the lst months of the year, mainly February and 
March, even though the PP was relatively well defined 
to the first half of the year, there were exceptions, such 
as Celtis spp, which was present almost ali year and 
Cupressus spp started in September and persisted until 
March-April. This causes approaching challenges in 
polysensitized patients because, even in the same 
group of plants PPs can overlap, causing clinical sym~ 
toms with exacerbations at different times of the year. 
Pinus spp corresponded to 4.25% of the total count and 
was observed mainly from February to July, regardless 
of the fact that it is found in important quantity, the 
days with high pollen counts were few7 and its alier-
genic importance is not as relevant as other species, 
such as Fraxinus ~p, Morus spp, Cupressus spp, and 
Ricinus communis. 
The interpretation of the results of Gram.ineae/ 
Poaceae shows a similar risk of causing symptoms 
such as Fraxinus spp. (SO days versus 49 days, respec-
tively). This is not simple in clinical terms because 
grasses cause symptoms at smalier grain counts and it 
is easier to find patients with symptoms induced by 
grasses than trees, with a ratio of 4:1.39 The largest 
amount was 420 grains/m3 (December 21, 2004); the 
PP lasted almost ali year (10 months). Patients sensitive 
to grasses would have more variability in their symp-
toms during December, because the average was hiJíh 
enough to cause pollinosis (26 grains/m3 per day). 
Despite the advantages offered by the Hirst sampler, 
a defect in our study is the lack of data on the hourly 
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Table 3 Relevant plants from an allergenic perspective 
Taxa Concentration with Risk of 
Pollinosis• (days) 
Main Pollination Period 
Trees 
Cupressus spp 
Fraxinus spp 
f unglans spp 
Ligustrum spp 
Morus spp 
Prosopls spp 
Quercus spp 
Platanus spp 
Pinus spp 
Weeds 
19 
49 
3 
4 
30 
7 
7 
10 
7 
January-April 
January-April 
March-May 
March-June 
February-May 
March-June 
February-May 
February-March 
February-August 
\..... Amaranthaceae/Chenopodiaceae 22 April-December 
Ambrosia spp 20 May-December 
Helianthus spp 7 May-November 
Parietaria spp 30 February-September 
Ricinnus spp 18 January-October 
Artemisa spp 3 August-October 
Grasses 
Gramineae/Poaceae 50 April-January 
First column describes relevant taxa, second column describes the number of days with concentrations > 15 grains/m3 per day 
for trees, > 10 grains/m3 per day for weeds, and >5 grains/m3 per day for grasses, and the third column describes main 
pollination period. 
•clinically relevant according to the Burge categorization system. 
variation of pollen for each taxa, especially those with 
allergenic importance. Sorne studies have reported the 
release of pollen from 8 A.M. to 2 P.M. with a maxi-
mum peak between 10 A.M. and 12 P.M.39 
Factors such as climate change, relative humidity, 
wind, pollution level, and altitude1·40 can influence the 
presence of pollen, i.e., pollen production for Ambrosia 
spp occurs after sunrise (Bianchi 1951 and Ogden 1969) 
and levels decrease during rainy seasons.39 Other au-
thors have observed that rain hinders the abnospheric 
pollen count and the symptomology of affected indi-
viduals usually decreases, if patients really have polli-
nosis.41 
This study identifies the rnain pollens in the city of 
Monterrey and their variation during the year; a better 
estimate may be obtained averaging pollen data ob-
tained over severa! years, but, unfortunately, we have 
only completed 1 year. There is a similar behavior 
among tree, weed, and grass pollen during the year 
according to Cueva-Velazquez14 and Corona,12 but it is 
important to point out that these studies were reported 
>40 years ago. A common phenornenon in our setting 
is that PPs overlap, and sorne types of pollen are 
present practically all year. This behavior of pollen 
explains why the patient with perennial disease has 
seasonal exacerbations, because many allergy .gatients 
are sensitive to more than one aeroallergen. How-
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ever, even in urbanized areas there is an overlapping 
about native species and plants that have been adopted 
because of gradual urbanization. A report developed 
in parallel with this study was done in a different 
location of Monterrey (north area), by the same per-
sonnel of the School of Biologic Sciences, and there 
were sorne differences in pollen count, i.e., higher lev-
els of Cupressus spp. and Amaranthaceae/Chenopodi-
aceae pollen, than in our study with the other pollen 
levels almost the same43; this correlates that differences 
in the concentration of pollen in the air depend on the 
vegetation features in each region and even in different 
areas of the same city.13•44 This is important to predict 
the type of sensitivity that we can expect to find in 
allergic patients. Also, we can estímate the risk of 
exacerbation of symptorns in the allergic population if 
we know the behavior of pollen in each region; e.g., 
Schmier performed a review summarizing existing 
asthma-related impact of aeroallergen exposure litera-
ture, and despite that little is known about this rela-
tionship, there appears to be evidence that weed pollen 
is associated with asthma exacerbations.45 
Pollen sampling with different devices is used only 
as a guide. Sorne studies with personal sampling de-
vices have shown variability depending on the level 
where the device is placed (patient level or severa! 
meters above the ground).34 A fact well known is that 
July-August 2010, Vol. 31, No. 4 
ery sensitive patients can present an allergic response 
ith small doses of pollen,46 which makes the atmo-
pheric counts and aeroallergen sensitization patterns 
several or single allergens) important for the clinician; 
owever, it should always be considered that the pa-
·ent can be more sensitive !han the pollen detector 
device.39 
ONCLUSIONS 
Tree pollen represented most of the pollen collected, 
ainly from lhe months of January-March, with Fraxi-
us spp having the highest concentration. Weed and 
ass pollen were perennial presenting sorne peaks 
uring the year. 
PP for trees and grass is similar in other cities, such 
s Mexico City, Zacatecas, Tamaulipas, Tepic, Vera-
' Toluca, and Guadalajara, from November to May 
·th each geographical area having its own features. 
or weeds the PP was mainly from June to October, 
with the higher atmospheric concentration reported at 
the end of the summer and beginning of autumn. In 
Monterrey, no well-defined period was observed, be-
cause several peaks occurred during the year. Plants 
such as Parietaria spp, Morus spp, Cupressus spp, and 
Ricinus communis represent recently found allergens in 
this region relevant for diagnosis and treatment, be-
cause allergy to these has been observed. In polysen-
sitized patients a perennial pattem of symptoms is 
more common with several exacerbations during the 
year. December, January, February, March, and April 
were the months with the highest concentration of 
pallen count. lt is important to be aware of this for an 
appropriate clinical approach of allergic patients. 
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